"Vaccine safety" trang 1 - tải miễn phí từ tailieunhanh
Safety of measles and rubella combined vaccine manufacturing by POLYVAC in Vietnamese volunteers

Safety of measles and rubella combined vaccine manufacturing by POLYVAC in Vietnamese volunteers
5    81    0
Summary of Public health Doctoral Thesis: Evaluation of the immunogenicity and safety of IVACFLU-A / H5N1 vaccine in healthy adult vietnamese

Summary of Public health Doctoral Thesis: Evaluation of the immunogenicity and safety of IVACFLU-A / H5N1 vaccine in healthy adult vietnamese
31    43    1
Safety of measles and rubella combined vaccine manufactering by polyvac in Vietnamese volunteers

Safety of measles and rubella combined vaccine manufactering by polyvac in Vietnamese volunteers
5    69    0
The immunogenicity, safety, and consistency of an Indonesia combined DTP-HB-Hib vaccine in expanded program on immunization schedule

The immunogenicity, safety, and consistency of an Indonesia combined DTP-HB-Hib vaccine in expanded program on immunization schedule
10    85    0
Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: A phase III, double-blind, randomized study

Safety and immunogenicity of a varicella vaccine without human serum albumin (HSA) versus a HSA-containing formulation administered in the second year of life: A phase III, double-blind, randomized study
8    63    0
Báo cáo y học:

Báo cáo y học: "Safety, immunogenicity and preliminary efficacy of multiple-site vaccination with an Epidermal Growth Factor (EGF) based cancer vaccine in advanced non small cell lung cancer (NSCLC) patients"
6    70    0
Báo cáo y học:

Báo cáo y học: " Phytol-based novel adjuvants in vaccine formulation: 1. assessment of safety and efficacy during stimulation of humoral and cell-mediated immune responses"
11    38    0
Báo cáo y học:

Báo cáo y học: "Correction: Phytol-based novel adjuvants in vaccine formulation: 1. assessment of safety and efficacy during stimulation of humoral and cell-mediated immune responses"
1    52    0
Surveillance for Safety After Immunization: Vaccine Adverse Event Reporting System (VAERS) — United States, 1991–2001

Surveillance for Safety After Immunization: Vaccine Adverse Event Reporting System (VAERS) — United States, 1991–2001
28    52    1
DTwP-HB-Hib: Antibody persistence after a primary series, immune response and safety after a booster dose in children 18–24 months old

DTwP-HB-Hib: Antibody persistence after a primary series, immune response and safety after a booster dose in children 18–24 months old
8    62    0
Risk of seizures after immunization in children with epilepsy: A risk interval analysis

Risk of seizures after immunization in children with epilepsy: A risk interval analysis
7    55    0
“Lay epidemiology”: An important factor in Danish parents’ decision of whether to allow their child to receive a BCG vaccination: A qualitative exploration of parental perspective

“Lay epidemiology”: An important factor in Danish parents’ decision of whether to allow their child to receive a BCG vaccination: A qualitative exploration of parental perspective
8    65    0